Little is yet known about this vector-borne disease that has been diagnosed in only one human to date and appears confined to Gulf Coast states, but researchers are investigating to learn more.
The cause of migraines remain unknown, but research continues and many evolving treatments are reducing the frequency and pain of migraines.
Can marijuana be used as an adjunct to or substitute for opioids in the treatment of chronic pain
to potentially alleviate the opioid crisis?
Once thought to be a useless byproduct, umbilical cord blood now treats more than 80 diseases, and it may soon be used to treat more.
A potential solution for CIDP patients with these IVIG-related issues is self-administered subcutaneous immune globulin.
Better understanding of this condition is needed to demystify it and dispel the notion that the suffering is all in one’s head.
Touted as the future of medicine, AI also has many ethical unknowns that will require discussion apace with progress.
Approvals in 2018 brought the total number of U.S. Food and Drug Administration-licensed biosimilars well into the double digits — and more are in the pipeline.
